← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUCTA · Approved 2022-11-30

Drug application

FDA Application #

ANDA215332

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AUCTA

Manufacturer

EPIC PHARMA, LLC

First approval

2022-11-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown